Immunotherapy of cancer in the era of checkpoint inhibitor

被引：0
|
作者：
Inderjit Mehmi
Omid Hamid
机构：
[1] The Angeles Clinic and Research Institute,
[2] Cedar Sinai Affiliate,undefined
来源：
Clinical & Experimental Metastasis | 2022年 / 39卷
关键词：
Melanoma; cSCC; MCC; Immunotherapy; Checkpoint inhibitors; TIM-3; LAG-3; Cytokines; NSCLC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Application of immunotherapy has revolutionized treatment of number of malignancies. We present a review of immunotherapy approaches, early-phase data of number of new immunotherapeutic targets in melanoma, cutaneous squamous cell carcinoma, Merkel cell cancer, and non-small cell lung cancer.
引用
收藏
页码：231 / 237
页数：6
相关论文
共 50 条
  • [31] Central Nervous System Autoimmunity associated with Immune Checkpoint Inhibitor Cancer Immunotherapy
    Valencia-Sanchez, C.
    Sechi, E.
    Dubey, D.
    Flanagan, E.
    McKeon, A.
    Pittock, S.
    Zekeridou, A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 170 - 170
  • [32] The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment
    Hardaker, Elizabeth L.
    Sanseviero, Emilio
    Karmokar, Ankur
    Taylor, Devon
    Milo, Marta
    Michaloglou, Chrysis
    Hughes, Adina
    Mai, Mimi
    King, Matthew
    Solanki, Anisha
    Magiera, Lukasz
    Miragaia, Ricardo
    Kar, Gozde
    Standifer, Nathan
    Surace, Michael
    Gill, Shaan
    Peter, Alison
    Talbot, Sara
    Tohumeken, Sehmus
    Fryer, Henderson
    Mostafa, Ali
    Mulgrew, Kathy
    Lam, Carolyn
    Hoffmann, Scott
    Sutton, Daniel
    Carnevalli, Larissa
    Calero-Nieto, Fernando J.
    Jones, Gemma N.
    Pierce, Andrew J.
    Wilson, Zena
    Campbell, David
    Nyoni, Lynet
    Martins, Carla P.
    Baker, Tamara
    de Almeida, Gilberto Serrano
    Ramlaoui, Zainab
    Bidar, Abdel
    Phillips, Benjamin
    Boland, Joseph
    Iyer, Sonia
    Barrett, J. Carl
    Loembe, Arsene-Bienvenu
    Fuchs, Serge Y.
    Duvvuri, Umamaheswar
    Lou, Pei-Jen
    Nance, Melonie A.
    Gomez Roca, Carlos Alberto
    Cadogan, Elaine
    Critichlow, Susan E.
    Fawell, Steven
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [33] Toxicities associated with checkpoint inhibitor immunotherapy: The Karmanos Cancer Center experience.
    Nagasaka, Misako
    Alhasan, Roba S.
    Crosby, Marcus
    Thummala, Nithin
    Kim, Seongho
    Abrams, Judith
    Sukari, Ammar
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [34] The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
    Havel, Jonathan J.
    Chowell, Diego
    Chan, Timothy A.
    NATURE REVIEWS CANCER, 2019, 19 (03) : 133 - 150
  • [35] The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
    Jonathan J. Havel
    Diego Chowell
    Timothy A. Chan
    Nature Reviews Cancer, 2019, 19 : 133 - 150
  • [36] Oral toxicity associated with checkpoint inhibitor immunotherapy
    Chiang, P.
    Chen, C.
    Chen, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (09) : B25 - B25
  • [37] Checkpoint blockade in cancer immunotherapy
    Korman, AJ
    Peggs, KS
    Allison, JP
    ADVANCES IN IMMUNOLOGY, VOL 90: CANCER IMMUNOTHERAPY, 2006, 90 : 297 - 339
  • [38] In the era of cancer immunotherapy: time for pharmacist to redefine the prescription validation of immune checkpoint inhibitors
    Clarenne, J.
    Slimano, F.
    Boulanger, C.
    Marechal, A.
    Hettler, D.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 305 - 305
  • [39] Toxicity in the era of immune checkpoint inhibitor therapy
    Keam, Synat
    Turner, Naimah
    Kugeratski, Fernanda G.
    Rico, Rene
    Colunga-Minutti, Jocelynn
    Poojary, Rayansh
    Alekseev, Sayan
    Patel, Anisha B.
    Li, Yuanteng Jeff
    Sheshadri, Ajay
    Loghin, Monica E.
    Woodman, Karin
    Aaroe, Ashley E.
    Hamidi, Sarah
    Iyer, Priyanka Chandrasekhar
    Palaskas, Nicolas L.
    Wang, Yinghong
    Nurieva, Roza
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [40] Development of a peptide-based tumor-activated checkpoint inhibitor for cancer immunotherapy
    Zhao, Zhen
    Fetse, John
    Mamani, Umar-Farouk
    Guo, Yuhan
    Li, Yuanke
    Patel, Pratikkumar
    Liu, Yanli
    Lin, Chien-Yu
    Li, Yongren
    Mustafa, Bahaa
    Cheng, Kun
    ACTA BIOMATERIALIA, 2025, 193 : 484 - 497
12345